Ardelyx (ARDX) Capital Expenditures (QoQ) (2014 - 2026)
Ardelyx (ARDX) Capital Expenditures (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.89% |
| Dec 31, 2025 | 131.41% |
| Sep 30, 2025 | -76.00% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | -45.19% |
| Dec 31, 2024 | 332.85% |
| Sep 30, 2024 | 4.58% |
| Jun 30, 2024 | -12.67% |
| Mar 31, 2024 | 248.84% |
| Dec 31, 2023 | -77.84% |
| Sep 30, 2023 | 108.60% |
| Jun 30, 2023 | 564.29% |
| Mar 31, 2023 | -74.55% |
| Dec 31, 2021 | -121.35% |
| Sep 30, 2021 | -39.78% |
| Jun 30, 2021 | -5.01% |
| Mar 31, 2021 | 211.20% |
| Dec 31, 2020 | 410.20% |
| Sep 30, 2019 | 147.83% |
| Jun 30, 2019 | -72.12% |